Komori
Earnings7071Amvis Holdings,Inc.Information and Communications, Services and Others

Summary of Financial Results for the Second Quarter (Interim Period) of the Fiscal Year Ending September 2026 [Japanese GAAP] (Consolidated)

During the interim period, revenue increased 7.5% year on year, while operating income decreased 25.1% and interim net income attributable to owners of the parent decreased 29.5%. The reportable segments were also changed to two segments: 医心館 (medical care facilities) and Comprehensive Medical Support.

Worth reading
55In focus
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Mixed performance
Direction inferred from the company’s description.
Scale
939
million yen (decrease in operating profit)
Wording
Conditional
How definitive the wording is.

Results for this period

Interim period (second quarter)1 October 2025–31 March 2026ConsolidatedJapanese GAAP
Net Sales25,600¥ millionYear on year +7.5%Progress 49.5%
Operating profit2,804¥ millionYear on year -25.1%Progress 73.8%
Ordinary income2,789¥ millionYear on year -26.8%Progress 84.5%
Net income attributable to owners of the parent1,896¥ millionYear on year -29.5%Progress 90.3%

The width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.

Net income per share¥19.41
Financial position at period-end
Total assets83,923¥ million
of which net assets 37,938 ¥ millionEquity ratio 45.2%vs. prior year-end +2.2pt

塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.

Cash inflows and outflows
Operating+3,766
Investment-3,228
Financials-2,160
Net change-1,622

Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ million).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.

Cash and cash equivalents at end of period¥9,210 million
Segment revenueIshinkan medical care residences ¥25,033 million (YoY +6.1%), Comprehensive Medical Support ¥569 million (YoY +149.6%)
Segment profitIshinkan medical care residences ¥2,479 million (YoY -32.5%), Comprehensive Medical Support ¥324 million (YoY +375.7%)
Outlook and shareholder returns
Full-year earnings forecast
Net Sales¥51,700 million (YoY +5.1%)
Operating profit¥3,800 million (YoY -38.3%)
Ordinary income¥3,300 million (YoY -48.0%)
Net income¥2,100 million (YoY -42.6%)
Revision to Earnings ForecastNo revision
Annual Dividend Forecast¥4 → ¥4(0.0%)
Factors Behind Changes in Business Performance

At 医心館 (medical care facilities), revenue increased due to the ramp-up in utilization at facilities opened in the previous fiscal year, despite a temporary decline in facility utilization due to the response to the Special Investigation Committee and other factors. Profit declined as gross profit margin fell because personnel expenses increased due to the advance assignment of staff in connection with the opening of new facilities and efforts to secure personnel. Comprehensive Medical Support recorded higher revenue and profit as the number of supported medical institutions increased by 2 and services for existing supported institutions were expanded.

Disclosure regarding the going concern assumption

No applicable matters

Change in accounting policy
基準改正に伴う変更 Noそれ以外の変更 No見積りの変更 No修正再表示 No
Changes in the scope of consolidationNew Number of companies 0 / Company name Not disclosed / Excluded Number of companies 0 / Company name Not disclosed
Breakdown of extraordinary income (loss)Extraordinary income Gain on business transfer ¥34 million / Extraordinary loss Loss on Disposal of Fixed Assets ¥14 million
Depreciation and amortization¥1,587 million
Availability of Supplementary Financial Results MaterialsYes
Availability of Financial Results BriefingWhether applicable Yes / Subject person Not disclosed
Issued Shares at Period-End98,112,000 shares
Treasury Shares at Period-End7,257 shares
Results for this period
ItemDetails
Fiscal Period ClassificationInterim period (second quarter)
Accounting standardsJapanese GAAP
Consolidated / non-consolidatedConsolidated
Period Covered1 October 2025–31 March 2026
Net Sales¥25,600 million (YoY +7.5%)
Operating profit¥2,804 million (YoY -25.1%)
Ordinary income¥2,789 million (YoY -26.8%)
Profit attributable to owners of the parent¥1,896 million (YoY -29.5%)
Net income per share¥19.41
Equity ratioEnd of the current fiscal period 45.2% / End of previous period 43.0%
Total assets¥83,923 million
Net assets¥37,938 million
Cash flows from operating activities¥3,766 million
Cash flows from investing activities¥-3,228 million
Cash flows from financing activities¥-2,160 million
Cash and cash equivalents at end of period¥9,210 million
Full-year earnings forecastNet Sales ¥51,700 million (YoY +5.1%) / Operating profit ¥3,800 million (YoY -38.3%) / Ordinary income ¥3,300 million (YoY -48.0%) / Net income ¥2,100 million (YoY -42.6%)
Revision to Earnings ForecastNo revision
Annual Dividend Forecast¥4 → ¥4(0.0%)
Segment revenueIshinkan medical care residences ¥25,033 million (YoY +6.1%), Comprehensive Medical Support ¥569 million (YoY +149.6%)
Segment profitIshinkan medical care residences ¥2,479 million (YoY -32.5%), Comprehensive Medical Support ¥324 million (YoY +375.7%)
Depreciation and amortization¥1,587 million
Breakdown of extraordinary income (loss)Extraordinary income Gain on business transfer ¥34 million / Extraordinary loss Loss on Disposal of Fixed Assets ¥14 million
Disclosure regarding the going concern assumptionNo applicable matters
Change in accounting policyChanges due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No
Changes in the scope of consolidationNew Number of companies 0 / Company name Not disclosed / Excluded Number of companies 0 / Company name Not disclosed
Availability of Supplementary Financial Results MaterialsYes
Availability of Financial Results BriefingWhether applicable Yes / Subject person Not disclosed
Issued Shares at Period-End98,112,000 shares
Treasury Shares at Period-End7,257 shares
Factors Behind Changes in Business PerformanceAt 医心館 (medical care facilities), revenue increased due to the ramp-up in utilization at facilities opened in the previous fiscal year, despite a temporary decline in facility utilization due to the response to the Special Investigation Committee and other factors. Profit declined as gross profit margin fell because personnel expenses increased due to the advance assignment of staff in connection with the opening of new facilities and efforts to secure personnel. Comprehensive Medical Support recorded higher revenue and profit as the number of supported medical institutions increased by 2 and services for existing supported institutions were expanded.
Items this document does not state (7)
Operating MarginPayout ratioShareholder Return PolicyRegional salesOrders received and order backlogImpairment lossMaterial subsequent events

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

At 医心館 (medical care facilities), facility utilization temporarily declined due to the response to the Special Investigation Committee and other factors. Gross profit margin also declined because personnel expenses increased due to the advance assignment of staff in connection with the opening of new facilities and efforts to secure personnel. Comprehensive Medical Support recorded higher revenue and profit due to an increase in supported medical institutions and the expansion of services provided.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Summary of Financial Results for the Second Quarter (Interim Period) of the Fiscal Year Ending September 2026 [Japanese GAAP] (Consolidated) | Amvis Holdings,Inc. (7071) timely disclosure | Komori